Non-specific removal of antibodies in patients with idiopathic dilated cardiomyopathy: Implications for xenotransplantation

Journal of Heart and Lung Transplantation

Volumn 23, Issue 5, 2004, Pages 623-626

  Knosalla, Christoph ^a,b   Müller, Johannes ^a   Moran, Kathleen ^c   Wallukat, Gerd ^d   Hetzer, Roland ^a   Cooper, David K C ^b  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Immerge Biotherapeutics Inc   (United States)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSYLGALACTOSE; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; BLOOD TOXICITY; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; EXTRACORPOREAL IMMUNOADSORPTION; HEART FAILURE; HUMAN; MALE; NONHUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; SAFETY; SWINE; TREATMENT INDICATION; XENOTRANSPLANTATION;

ADULT; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; AUTOANTIBODIES; CARDIOMYOPATHY, DILATED; DISACCHARIDES; HEART; HEART TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSORBENT TECHNIQUES; MALE; MIDDLE AGED; MYOCARDIUM; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 2342521160     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(03)00229-8     Document Type: Article

References (10)

1. Kobayashi T., Cooper D.K.C. Anti-Gal, α-Gal epitopes, and xenotransplantation. Galili U., Avila J.L. α-Gal and Anti-Gal: α-1, 3-Galactosyltransferase, α-Gal Epitopes, and the Natural Anti-Gal Antibody. 1999;229-257 Kluwer Academic/Plenum, New York/London
2. Good A.H., Cooper D.K.C., Malcolm A.J., et al. Identification of carbohydrate structures that bind human antiporcine antibodies Implications for discordant xenografting in man. Transplant Proc. 24:1992;559-562
3. Xu Y., Lorf T., Sablinski T., et al. Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galα1-3Galβ-4Glc-X immunoaffinity column. Transplantation. 65:1998;172-179
4. Ramos A., Ruiz J.C., de Francisco A.L., Gomez-Fleitas M., Arias M. Removal of xenoreactive antibodies by protein-A immunoadsorption Experience in 22 patients. Xenotransplantation. 7:2000;14-20
5. Müller J., Wallukat G., Dandel M., et al. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation. 101:2000;385-391
6. Buonomano R., Tinguely C., Rieben R., Mohacsi P.J., Nydegger U.E. Quantitation and characterization of anti-Galalpha1-3Gal antibodies in sera of 200 healthy persons. Xenotransplantation. 6:1999;173-180
7. Teranishi K., Manez R., Awwad M., Cooper D.K.C. Anti-Galα1-3Gal IgM and IgG antibody levels in sera of humans and Old World non-human primates. Xenotransplantation. 9:2002;148-154
8. Gabrielli A., Leoni P., Davieli G., Hermann K., Krieg T., Wieslander J. Antibodies against galactosyl α(1-3)galactose in connective tissue diseases. Arthritis Rheum. 34:1991;375-376
9. Perez Fontan M., Manez R., Blanco F., Rodriguez-Carmona A. Natural anti-alpha- galactosyl antibodies in patients undergoing peritoneal dialysis and hemodialysis. Adv Perit Dial. 16:2000;216-218
10. Zhu A. Binding of human natural antibodies to nonαGal xenoantigens on porcine erythrocytes. Transplantation. 69:2000;2422-2428